Publication of Pricing Supplement
Source: RNS![](https://tracker.live.rns-distribution.com/track.live-rns/5321907_d9353a075fe0b610698e373da828b7e4.png)
NatWest Markets Plc
Publication of Pricing Supplement
The following Pricing Supplement is available for viewing:
Pricing Supplement dated 23 August 2024 (the "Pricing Supplement") for NatWest Markets Plc ("NatWest Markets") for the CHF 180,000,000 1.445% Notes due August 2029 (ISIN: CH1357852818) (the "Notes") issued under the £20,000,000,000 Euro Medium Term Note Programme of NatWest Markets (the "Programme").
The Pricing Supplement contains the final terms of the Notes and must be read in conjunction with the prospectus dated 7 December 2023 and the supplemental Prospectuses dated 16 February 2024, 18 March 2024, 26 April 2024 and 26 July 2024, relating to the Programme (together, the "Prospectus"), which constitute a base prospectus for the purposes of the Prospectus Regulation (EU) 2017/1129 as it forms part of domestic law in the UK by virtue of the European Union (Withdrawal) Act 2018.
To view the Pricing Supplement, please paste the following URL into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/6571B_1-2024-8-23.pdf
A copy of the above Final Terms has been submitted to the National Storage Mechanism and will shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For further information, please contact:
Mark Anwender
Head of Documentation and Funding
NatWest Treasury Markets
Tel: +44 7385 366760
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Final Terms (when read together with the information in the Prospectus) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and the Prospectus is not addressed. Prior to relying on the information contained in the Final Terms and the Prospectus, you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
NatWest Markets Plc - RR3QWICWWIPCS8A4S074
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.